Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 6—June 2018

Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission

Maxime HentzienComments to Author , Stéphanie Mestrallet, Pascale Halin, Laure-Anne Pannet, Delphine Lebrun, Moustapha Dramé, Firouzé Bani-Sadr, Jean-Marc Galempoix, Christophe Strady, Jean-Marc Reynes, Christian Penalba, and Amélie Servettaz
Author affiliations: University of Reims Champagne-Ardenne, Reims, France (M. Hentzien, M. Dramé); Hôpital Universitaire Robert Debré, Reims (M. Hentzien, M. Dramé, F. Bani-Sadr, A. Servettaz); Manchester Hospital, Charleville-Mézières, France (S. Mestrallet, P. Halin, L.-A. Pannet, D. Lebrun, J.-M. Galempoix, C. Penalba); Groupe Courlancy, Reims (C. Strady); Institut Pasteur, Lyon, France (J.-M. Reynes)

Main Article

Table 4

Events observed in patients hospitalized with NE by risk group as determined by bioclinical test score, Ardennes Department, France, January 2000–December 2014*

Risk group Score No. NE patients Observed severe NE, no. (%)
Low 0–10 61 2 (3.3)
Intermediate 11–19 80 14 (17.5)
High 20–45 53 24 (45.3)

*Data were missing for 11 patients, who were excluded in this analysis. However, similar results for observed severe NE were obtained when assuming a score of zero for missing data: low (4.7%, 3/64), intermediate (20.1%, 18/87), and high (44.4%, 24/54). The leukocyte count and platelet count at admission were missing from the 1 additional patient with severe NE categorized as low risk in this analysis. NE, nephropathia epidemica.

Main Article

Page created: May 15, 2018
Page updated: May 15, 2018
Page reviewed: May 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.